IGC Pharma
IGCPhase 2IGC Pharma revolutionizing the Future of Alzheimer´s care.
Market Cap
$27.2M
-7.7% period
Pipeline
2
drug candidates
Patents
—
Publications
—
IGC · Stock Price
USD 0.290.02 (-7.68%)
Historical price data
About
IGC Pharma revolutionizing the Future of Alzheimer´s care.
Small Molecules
Pipeline
22 drugs in pipeline
| Drug | Indication | Stage | Watch |
|---|---|---|---|
| IGC-AD1-Active + IGC-AD1-Placebo | Alzheimer Disease | Phase 2 | |
| IGC AD1 + Placebo | Dementia of Alzheimer Type | Phase 1 |
Funding History
2Total raised:$18M
IPO$10MFeb 15, 2021
Series A$8MJun 15, 2017